Manalo, Meljie M.

HRN: 20-44-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
CEFTRIAXONE 1G (VIAL)
09/12/2023
09/18/2023
IVT
750mg
Q12
Subperiosteal Abscess Right, Csom Ad
Waiting Final Action 
09/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/13/2023
09/20/2023
IV
200mg
Q 8hrs
Subperiosteal Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: